These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8123238)

  • 1. Sponge-gel-supported histoculture drug-response assay for head and neck cancer. Correlations with clinical response to cisplatin.
    Robbins KT; Connors KM; Storniolo AM; Hanchett C; Hoffman RM
    Arch Otolaryngol Head Neck Surg; 1994 Mar; 120(3):288-92. PubMed ID: 8123238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Correlation of the Histoculture Drug Response Assay for Head and Neck Cancer.
    Hoffman RM
    Methods Mol Biol; 2018; 1760():83-92. PubMed ID: 29572796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug response of head and neck tumors in native-state histoculture.
    Robbins KT; Varki NM; Storniolo AM; Hoffman H; Hoffman RM
    Arch Otolaryngol Head Neck Surg; 1991 Jan; 117(1):83-6. PubMed ID: 1986767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
    Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of survival in patients with head and neck cancer using the histoculture drug response assay.
    Singh B; Li R; Xu L; Poluri A; Patel S; Shaha AR; Pfister D; Sherman E; Goberdhan A; Hoffman RM; Shah J
    Head Neck; 2002 May; 24(5):437-42. PubMed ID: 12001073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro chemosensitivity profile of oral squamous cell cancer and its correlation with clinical response to chemotherapy.
    Pathak KA; Juvekar AS; Radhakrishnan DK; Deshpande MS; Pai VR; Chaturvedi P; Pai PS; Chaukar DA; D'Cruz AK; Parikh PM
    Indian J Cancer; 2007; 44(4):142-6. PubMed ID: 18322356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histoculture and the immunodeficient mouse come to the cancer clinic - rational approaches to individualizing cancer-therapy and new drug-evaluation (review).
    Hoffman R
    Int J Oncol; 1992 Sep; 1(4):467-74. PubMed ID: 21584568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High in vitro-in vivo correlation of drug response using sponge-gel-supported three-dimensional histoculture and the MTT end point.
    Furukawa T; Kubota T; Watanabe M; Takahara T; Yamaguchi H; Takeuchi T; Kase S; Kodaira S; Ishibiki K; Kitajima M
    Int J Cancer; 1992 May; 51(3):489-98. PubMed ID: 1592540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of the histoculture drug response assay.
    Furukawa T; Kubota T; Hoffman RM
    Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The measurement of glucose consumption in histoculture to determine effects of doxorubicin and cisplatinum on human gastric carcinoma.
    Chang SG; Chai SE; Kim ES; Yoon C; Joo HZ; Hoffman RM
    Anticancer Res; 1993; 13(5A):1303-10. PubMed ID: 8239500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
    Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
    Caponigro F; Di Gennaro E; Ionna F; Longo F; Aversa C; Pavone E; Maglione MG; Di Marzo M; Muto P; Cavalcanti E; Petrillo A; Sandomenico F; Maiolino P; D'Aniello R; Botti G; De Cecio R; Losito NS; Scala S; Trotta A; Zotti AI; Bruzzese F; Daponte A; Calogero E; Montano M; Pontone M; De Feo G; Perri F; Budillon A
    BMC Cancer; 2016 Nov; 16(1):918. PubMed ID: 27884140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer.
    Bussmann L; Busch CJ; Lörincz BB; Rieckmann T; Block A; Knecht R
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4073-4080. PubMed ID: 26755047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tumor cloning assay in advanced head and neck cancer. Prospective correlative trial.
    Mattox DE; Von Hoff DD; Harris LL
    Arch Otolaryngol; 1983 Nov; 109(11):724-6. PubMed ID: 6685472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic differentiation and chemosensitivity of human head and neck squamous cell carcinomas.
    Nakashima T; Maehara Y; Kohnoe S; Hayashi I; Katsuta Y
    Head Neck; 1990; 12(5):406-10. PubMed ID: 2211101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Notch1 expression and activation to cisplatin-sensitivity of head and neck squamous cell carcinoma.
    Zhang ZP; Sun YL; Fu L; Gu F; Zhang L; Hao XS
    Ai Zheng; 2009 Feb; 28(2):100-3. PubMed ID: 19550121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitivity testing of xenografted squamous cell carcinomas of the head and neck region.
    Elprana D; Kuijpers W; Wessels JM; Wagener DJ; van den Broek P
    Anticancer Res; 1992; 12(6B):2229-39. PubMed ID: 1284201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved response and survival to combined cisplatin and radiation in non-keratinizing squamous cell carcinomas of the head and neck. An RTOG study of 114 advanced stage tumors.
    Crissman JD; Pajak TF; Zarbo RJ; Marcial VA; Al-Sarraf M
    Cancer; 1987 Apr; 59(8):1391-7. PubMed ID: 2434208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to cisplatin determined by the histoculture drug response assay and clinical response of endometrial cancer.
    Kanasugi M; Aoki D; Suzuki N; Susumu N; Nakata S; Horiuchi M; Udagawa Y; Nozawa S
    Int J Gynecol Cancer; 2006; 16(1):409-15. PubMed ID: 16445667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.